JP2007516214A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007516214A5 JP2007516214A5 JP2006524916A JP2006524916A JP2007516214A5 JP 2007516214 A5 JP2007516214 A5 JP 2007516214A5 JP 2006524916 A JP2006524916 A JP 2006524916A JP 2006524916 A JP2006524916 A JP 2006524916A JP 2007516214 A5 JP2007516214 A5 JP 2007516214A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinant interferon
- seq
- interferon
- injection
- nucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000014150 Interferons Human genes 0.000 claims 9
- 108010050904 Interferons Proteins 0.000 claims 9
- 229940079322 interferon Drugs 0.000 claims 9
- 238000000034 method Methods 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 108700010070 Codon Usage Proteins 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 claims 1
- 230000004071 biological effect Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 239000007928 intraperitoneal injection Substances 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000007929 subcutaneous injection Substances 0.000 claims 1
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49844903P | 2003-08-28 | 2003-08-28 | |
| US49878503P | 2003-08-28 | 2003-08-28 | |
| US49892303P | 2003-08-28 | 2003-08-28 | |
| US60/498,449 | 2003-08-28 | ||
| US60/498,923 | 2003-08-28 | ||
| US60/498,785 | 2003-08-28 | ||
| IN280MU2004 | 2004-03-05 | ||
| IN279MU2004 | 2004-03-05 | ||
| IN279/MUM/2004 | 2004-03-05 | ||
| IN280/MUM/2004 | 2004-03-05 | ||
| PCT/US2004/028067 WO2005034853A2 (en) | 2003-08-28 | 2004-08-26 | Uses of interferons with altered spatial structure |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012121307A Division JP5709800B2 (ja) | 2003-08-28 | 2012-05-28 | 変えられた空間構造を備えるインターフェロン及びその応用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007516214A JP2007516214A (ja) | 2007-06-21 |
| JP2007516214A5 true JP2007516214A5 (enExample) | 2009-11-26 |
| JP5663768B2 JP5663768B2 (ja) | 2015-02-04 |
Family
ID=34280101
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006524916A Expired - Fee Related JP5663768B2 (ja) | 2003-08-28 | 2004-08-26 | 空間構造が変えられるインターフェロン及びその応用 |
| JP2006524917A Pending JP2007503812A (ja) | 2003-08-28 | 2004-08-26 | 空間構造によるタンパク質の機能の調節 |
| JP2011011325A Pending JP2011083292A (ja) | 2003-08-28 | 2011-01-21 | 空間構造によるタンパク質の機能の調節 |
| JP2012121307A Expired - Fee Related JP5709800B2 (ja) | 2003-08-28 | 2012-05-28 | 変えられた空間構造を備えるインターフェロン及びその応用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006524917A Pending JP2007503812A (ja) | 2003-08-28 | 2004-08-26 | 空間構造によるタンパク質の機能の調節 |
| JP2011011325A Pending JP2011083292A (ja) | 2003-08-28 | 2011-01-21 | 空間構造によるタンパク質の機能の調節 |
| JP2012121307A Expired - Fee Related JP5709800B2 (ja) | 2003-08-28 | 2012-05-28 | 変えられた空間構造を備えるインターフェロン及びその応用 |
Country Status (7)
| Country | Link |
|---|---|
| EP (3) | EP2325202B1 (enExample) |
| JP (4) | JP5663768B2 (enExample) |
| KR (2) | KR20060130009A (enExample) |
| AU (2) | AU2004269390A1 (enExample) |
| CA (2) | CA2535902A1 (enExample) |
| PL (2) | PL1663110T3 (enExample) |
| WO (2) | WO2005021777A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8551469B2 (en) | 2001-02-28 | 2013-10-08 | Superlab Far East Limited | Treatment of tumors and viral diseases with recombinant interferon alpha |
| CN1245215C (zh) | 2001-02-28 | 2006-03-15 | 四川省生物工程研究中心 | 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂 |
| US7585647B2 (en) | 2003-08-28 | 2009-09-08 | Guangwen Wei | Nucleic acid encoding recombinant interferon |
| EP2325202B1 (en) * | 2003-08-28 | 2014-10-22 | Superlab Far East Limited | Uses of interferons with altered spatial structure |
| WO2006076014A2 (en) * | 2004-04-30 | 2006-07-20 | Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Interferon-alpha constructs for use in the treatment of sars |
| AU2006257286B2 (en) * | 2005-03-09 | 2012-08-16 | Superlab Far East Limited | Uses of recombinant super-compound interferons |
| CN102101886A (zh) * | 2009-12-18 | 2011-06-22 | 四川辉阳生命工程股份有限公司 | 构象改变的重组干扰素晶体、其三维结构及应用 |
| TWI718086B (zh) | 2013-01-07 | 2021-02-11 | 英屬維爾京群島商遠東超級實驗室有限公司 | 通過干擾素的經皮和/或經粘膜給藥治療骨癌、皮膚癌、皮下癌、粘膜癌和/或粘膜下癌的方法和組合物 |
| CN111363726A (zh) | 2018-12-26 | 2020-07-03 | 上海元宋生物技术有限公司 | 表达干扰素的溶瘤病毒及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6936694B1 (en) | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
| US5372808A (en) | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
| EP0861321B1 (en) * | 1995-10-13 | 2006-05-31 | President And Fellows Of Harvard College | Phosphopantetheinyl transferases and uses thereof |
| US5874304A (en) * | 1996-01-18 | 1999-02-23 | University Of Florida Research Foundation, Inc. | Humanized green fluorescent protein genes and methods |
| US20020043262A1 (en) * | 2000-08-22 | 2002-04-18 | Alan Langford | Spray device |
| IL155741A0 (en) * | 2000-11-03 | 2003-12-23 | Pbl Biomedical Lab | Interferons, uses and compositions related thereto |
| CN1245215C (zh) * | 2001-02-28 | 2006-03-15 | 四川省生物工程研究中心 | 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂 |
| EP2325202B1 (en) * | 2003-08-28 | 2014-10-22 | Superlab Far East Limited | Uses of interferons with altered spatial structure |
-
2004
- 2004-08-26 EP EP10193126.9A patent/EP2325202B1/en not_active Expired - Lifetime
- 2004-08-26 EP EP04809634.1A patent/EP1663110B1/en not_active Expired - Lifetime
- 2004-08-26 PL PL04809634T patent/PL1663110T3/pl unknown
- 2004-08-26 KR KR1020067003699A patent/KR20060130009A/ko not_active Ceased
- 2004-08-26 KR KR1020067003700A patent/KR20060133949A/ko not_active Ceased
- 2004-08-26 CA CA002535902A patent/CA2535902A1/en not_active Abandoned
- 2004-08-26 EP EP04782529A patent/EP1670817A4/en not_active Ceased
- 2004-08-26 JP JP2006524916A patent/JP5663768B2/ja not_active Expired - Fee Related
- 2004-08-26 AU AU2004269390A patent/AU2004269390A1/en not_active Abandoned
- 2004-08-26 AU AU2004279350A patent/AU2004279350B2/en not_active Expired
- 2004-08-26 CA CA2535982A patent/CA2535982C/en not_active Expired - Lifetime
- 2004-08-26 PL PL10193126T patent/PL2325202T3/pl unknown
- 2004-08-26 WO PCT/US2004/028068 patent/WO2005021777A2/en not_active Ceased
- 2004-08-26 JP JP2006524917A patent/JP2007503812A/ja active Pending
- 2004-08-26 WO PCT/US2004/028067 patent/WO2005034853A2/en not_active Ceased
-
2011
- 2011-01-21 JP JP2011011325A patent/JP2011083292A/ja active Pending
-
2012
- 2012-05-28 JP JP2012121307A patent/JP5709800B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002523466A5 (enExample) | ||
| US8309531B2 (en) | Administration of interferon for prophylaxis against or treatment of pathogenic infection | |
| CA2529179A1 (en) | Recombinant adeno-associated virus vector for treatment of alzheimer disease | |
| CN103118699B (zh) | 白介素-22在治疗病毒性肝炎中的应用 | |
| JP2004525855A5 (enExample) | ||
| JP2003530839A5 (enExample) | ||
| JP2003505347A5 (enExample) | ||
| JP2011528896A5 (enExample) | ||
| JP2010520758A5 (enExample) | ||
| JP2007516214A5 (enExample) | ||
| JP2011518179A5 (enExample) | ||
| JP2014532722A5 (enExample) | ||
| JP2005508158A5 (enExample) | ||
| JPWO2021159118A5 (enExample) | ||
| JP2005525784A5 (enExample) | ||
| CN101137391B (zh) | 重组高效复合干扰素的用途 | |
| CN101463089B (zh) | 人血清白蛋白-干扰素融合蛋白及其编码基因与应用 | |
| JP2008512399A5 (enExample) | ||
| JP2009507474A5 (enExample) | ||
| CA2459230A1 (en) | Peptidic compounds selectively binding to p-selectin | |
| NZ583831A (en) | Protein-polymer conjugates comprising interferon-alpha | |
| JP2004529158A5 (enExample) | ||
| CN1161464C (zh) | 人表皮生长因子受体特异性融合蛋白及其应用 | |
| TWI421093B (zh) | 胜肽－聚合物綴合物 | |
| JP2003525251A5 (enExample) |